Last reviewed · How we verify
Non-steroidal mineralocorticoid receptor antagonist and SoC
Non-steroidal mineralocorticoid receptor antagonist and SoC is a Small molecule drug developed by Christian Medical College, Vellore, India. It is currently FDA-approved.
At a glance
| Generic name | Non-steroidal mineralocorticoid receptor antagonist and SoC |
|---|---|
| Sponsor | Christian Medical College, Vellore, India |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Non-steroidal mineralocorticoid receptor antagonist and SoC CI brief — competitive landscape report
- Non-steroidal mineralocorticoid receptor antagonist and SoC updates RSS · CI watch RSS
- Christian Medical College, Vellore, India portfolio CI
Frequently asked questions about Non-steroidal mineralocorticoid receptor antagonist and SoC
What is Non-steroidal mineralocorticoid receptor antagonist and SoC?
Non-steroidal mineralocorticoid receptor antagonist and SoC is a Small molecule drug developed by Christian Medical College, Vellore, India.
Who makes Non-steroidal mineralocorticoid receptor antagonist and SoC?
Non-steroidal mineralocorticoid receptor antagonist and SoC is developed and marketed by Christian Medical College, Vellore, India (see full Christian Medical College, Vellore, India pipeline at /company/christian-medical-college-vellore-india).
What development phase is Non-steroidal mineralocorticoid receptor antagonist and SoC in?
Non-steroidal mineralocorticoid receptor antagonist and SoC is FDA-approved (marketed).